Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
10.1038/s41408-020-0273-x
Saved in:
Main Authors: | Dimopoulos, M.A., Jakubowiak, A.J., McCarthy, P.L., Orlowski, R.Z., Attal, M., Bladé, J., Goldschmidt, H., Weisel, K.C., Ramasamy, K., Zweegman, S., Spencer, A., Huang, J.S.Y., Lu, J., Sunami, K., Iida, S., Chng, W.-J., Holstein, S.A., Rocci, A., Skacel, T., Labotka, R., Palumbo, A., Anderson, K.C. |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Review |
Published: |
Springer Nature
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198055 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study
by: Hartmut Goldschmidt, et al.
Published: (2018) -
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
by: Goldschmidt, Hartmut, et al.
Published: (2022) -
Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
by: San-Miguel, J, et al.
Published: (2020) -
IMWG consensus on risk stratification in multiple myeloma
by: Chng, W.J., et al.
Published: (2016) -
Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016)